AGIOS PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Stock Issued During Period, Shares, New Issues of 9.49 million shares for the 1-month period ending 2019-11-30, per its 10-K filed 2021-02-25.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2021-02-25
- 2019-11-30: Stock Issued During Period, Shares, New Issues 1 month 9.49M shares.
- 2018-01-31: Stock Issued During Period, Shares, New Issues 1 month 8.15M shares.
- 2017-04-30: Stock Issued During Period, Shares, New Issues 1 month 5.81M shares.
| Period end | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|
| 2019-11-30 | 9.49M shares 10-K · filed 2021-02-25 |
| 2018-01-31 | 8.15M shares 10-K · filed 2019-02-14 |
| 2017-04-30 | 5.81M shares 10-K · filed 2018-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |